Topic: Alzheimer.
Destination: The peripheral RFP is open to all biomarker categories that will advance drug development for Alzheimer’s and related dementias. The expected context of use, which defines a biomarker’s intended use clinically as a diagnostic or in drug development, should be described in the application.
Budget: Up to $500,000 (higher funding if well justified).
Duration: Not indicated.
Fill out the form below to receive more information: